Voloridge Investment Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-86,599
| Closed | -$2.77M | – | 1374 |
|
|
2024
Q3 | $2.77M | Buy |
86,599
+8,876
| +11% | +$284K | 0.01% | 890 |
|
|
2024
Q2 | $2.93M | Buy |
77,723
+63,395
| +442% | +$2.39M | 0.01% | 876 |
|
|
2024
Q1 | $705K | Sell |
14,328
-486,421
| -97% | -$23.9M | ﹤0.01% | 1013 |
|
|
2023
Q4 | $18.3M | Buy |
500,749
+426,246
| +572% | +$15.6M | 0.07% | 342 |
|
|
2023
Q3 | $1.72M | Sell |
74,503
-117,747
| -61% | -$2.72M | 0.01% | 963 |
|
|
2023
Q2 | $5.04M | Sell |
192,250
-158,544
| -45% | -$4.16M | 0.02% | 670 |
|
|
2023
Q1 | $9.03M | Buy |
350,794
+23,524
| +7% | +$606K | 0.04% | 475 |
|
|
2022
Q4 | $8.51M | Sell |
327,270
-123,724
| -27% | -$3.22M | 0.05% | 477 |
|
|
2022
Q3 | $12.9M | Buy |
450,994
+8,662
| +2% | +$247K | 0.07% | 374 |
|
|
2022
Q2 | $10.9M | Buy |
442,332
+422,918
| +2,178% | +$10.4M | 0.06% | 412 |
|
|
2022
Q1 | $1.1M | Buy |
19,414
+11,262
| +138% | +$636K | 0.01% | 1111 |
|
|
2021
Q4 | $505K | Sell |
8,152
-4,826
| -37% | -$299K | ﹤0.01% | 1407 |
|
|
2021
Q3 | $823K | Sell |
12,978
-40,538
| -76% | -$2.57M | 0.01% | 1336 |
|
|
2021
Q2 | $4.41M | Buy |
53,516
+1,759
| +3% | +$145K | 0.03% | 690 |
|
|
2021
Q1 | $3.81M | Buy |
51,757
+39,800
| +333% | +$2.93M | 0.03% | 612 |
|
|
2020
Q4 | $867K | Buy |
+11,957
| New | +$867K | 0.01% | 1009 |
|